Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Medical Journal of Australia
|
May 25, 2006
Emphysematous pyelonephritis
John V Peter, Vishwanath Biradar, Sandra L Peake
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
January 26, 2011
Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit
Vishwanath Biradar, John L Moran, Sandra L Peake, et al.
Plos One
|
November 9, 2016
Stress Induced Hyperglycemia and the Subsequent Risk of Type 2 Diabetes in Survivors of Critical Illness
Mark P Plummer, Mark E Finnis, Liza K Phillips, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
December 5, 2017
Long-term mortality of critically ill patients with diabetes who survive admission to the intensive care unit
Yasmine Ali Abdelhamid, Mark P Plummer, Mark E Finnis, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses
|
October 24, 2018
Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care units
Alexis P Poole, James Anstey, Rinaldo Bellomo, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 24, 2022
The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial
Alexis P Poole, Mark E Finnis, James Anstey, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
May 12, 2020
Study protocol and statistical analysis plan for the Liberal Glucose Control in Critically Ill Patients with Pre-existing Type 2 Diabetes (LUCID) trial
Alexis P Poole, Mark E Finnis, James Anstey, et al.
JAMA
|
September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Medical Journal of Australia
|
May 25, 2006
Emphysematous pyelonephritis
John V Peter, Vishwanath Biradar, Sandra L Peake
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
January 26, 2011
Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit
Vishwanath Biradar, John L Moran, Sandra L Peake, et al.
Plos One
|
November 9, 2016
Stress Induced Hyperglycemia and the Subsequent Risk of Type 2 Diabetes in Survivors of Critical Illness
Mark P Plummer, Mark E Finnis, Liza K Phillips, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
December 5, 2017
Long-term mortality of critically ill patients with diabetes who survive admission to the intensive care unit
Yasmine Ali Abdelhamid, Mark P Plummer, Mark E Finnis, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses
|
October 24, 2018
Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care units
Alexis P Poole, James Anstey, Rinaldo Bellomo, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 24, 2022
The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial
Alexis P Poole, Mark E Finnis, James Anstey, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine
|
May 12, 2020
Study protocol and statistical analysis plan for the Liberal Glucose Control in Critically Ill Patients with Pre-existing Type 2 Diabetes (LUCID) trial
Alexis P Poole, Mark E Finnis, James Anstey, et al.
JAMA
|
September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Page
of 1